ATE90388T1 - Schuetzendes peptid-antigen. - Google Patents

Schuetzendes peptid-antigen.

Info

Publication number
ATE90388T1
ATE90388T1 AT84900931T AT84900931T ATE90388T1 AT E90388 T1 ATE90388 T1 AT E90388T1 AT 84900931 T AT84900931 T AT 84900931T AT 84900931 T AT84900931 T AT 84900931T AT E90388 T1 ATE90388 T1 AT E90388T1
Authority
AT
Austria
Prior art keywords
peptide
prepared
peptide antigen
analog
protective peptide
Prior art date
Application number
AT84900931T
Other languages
English (en)
Inventor
David R Colman
Joan Ellis
G Nigel Godson
Ruth S Nussenzweig
Victor N Nussenzweig
David H Schlesinger
Pamela S Svec
Fidel Zavala
Original Assignee
Univ New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York filed Critical Univ New York
Application granted granted Critical
Publication of ATE90388T1 publication Critical patent/ATE90388T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Detergent Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
AT84900931T 1983-01-28 1984-01-27 Schuetzendes peptid-antigen. ATE90388T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB08302349A GB2145092B (en) 1983-01-28 1983-01-28 Protective peptide antigen
PCT/US1984/000144 WO1984002922A1 (en) 1983-01-28 1984-01-27 Protective peptide antigen

Publications (1)

Publication Number Publication Date
ATE90388T1 true ATE90388T1 (de) 1993-06-15

Family

ID=10537081

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84900931T ATE90388T1 (de) 1983-01-28 1984-01-27 Schuetzendes peptid-antigen.

Country Status (13)

Country Link
EP (1) EP0134242B1 (de)
JP (1) JPS60500215A (de)
AT (1) ATE90388T1 (de)
AU (1) AU571202B2 (de)
DE (1) DE3486159T2 (de)
DK (1) DK461884D0 (de)
GB (2) GB2145092B (de)
IE (1) IE56627B1 (de)
IL (1) IL70800A (de)
IT (1) IT1180160B (de)
NZ (2) NZ230526A (de)
WO (1) WO1984002922A1 (de)
ZA (1) ZA84638B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU569722B2 (en) * 1983-01-28 1988-02-18 Saramane Pty Ltd Expression of plasmodium falciparum polypeptides from cloned cdna
EP0135108A3 (de) * 1983-08-12 1988-07-13 Rockefeller University Nukleotider Hybridisierungstest für parasitische Protozoen
WO1985003724A1 (en) * 1984-02-21 1985-08-29 National Research Development Corporation Improvements in or relating to the production of malaria vaccines
DE3583347D1 (de) * 1984-02-22 1991-08-08 Wellcome Found Klonieren von dna fuer protozoenantigene.
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
FR2566780B1 (fr) * 1984-07-02 1987-02-06 Pasteur Institut Molecules comportant au moins une sequence peptidique porteuse d'un epitope caracteristique d'une proteine produite par des cellules infectees par les parasites du paludisme et compositions les contenant
US5126264A (en) * 1984-09-11 1992-06-30 The Walter & Eliza Hall Institute Of Medical Research The RESA and FIRA antigens of plasmodium falciparum
EP0192626B1 (de) * 1985-02-07 1992-07-29 Smithkline Beecham Corporation Malaria-Impfstoff
CN86100979A (zh) * 1985-02-07 1986-12-17 史密丝克莱恩贝克曼公司 疟疾疫苗的制备方法
IL78476A0 (en) * 1985-04-11 1986-08-31 Inst Medical W & E Hall Highly repetitive antigens of plasmodium falciparum
WO1987000533A1 (en) * 1985-07-12 1987-01-29 New York University Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein
US5866363A (en) * 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
IL79881A (en) * 1985-08-28 1995-12-08 Pieczenik George Populations of random coding series of oligonucleotides and peptides
US4693994A (en) * 1985-11-19 1987-09-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Protective synthetic peptide against malaria and encoding gene
GB8615068D0 (en) * 1986-06-20 1986-07-23 Wellcome Found Vaccines
US4897354A (en) * 1986-07-28 1990-01-30 University Of Hawaii Monoclonal antibody-specific merozoite antigens
IT1213576B (it) * 1986-12-23 1989-12-20 Eniricerche Spa Composizione polipeptidica utile per la preparazione di vaccini antimalaria e di kits diagnostici per la determinazione di anticorpi antimerozoite.
AP56A (en) * 1987-01-30 1989-09-26 Smithkline Biologicals S A Hepatitis B virus surface antigens and hybrid antigehs containing them.
WO1993011157A1 (en) * 1991-11-27 1993-06-10 The Council Of The Queensland Institute Of Medical Research MALARIAL VACCINE AND PEPTIDES COMPRISING HUMAN T-CELL EPITOPE OF CIRCUMSPOROZOITE PROTEIN OF $i(P.VIVAX)
PL2067414T3 (pl) 2007-12-04 2011-07-29 Hauni Maschinenbau Ag Urządzenie do kształtowania pasma maszyny stosowanej w przemyśle tytoniowym
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3382194D1 (de) * 1982-12-27 1991-04-11 Pasteur Institut Polypeptidfraktionen die gegen malariaparasiten schuetzende antikoerper induzieren und dieselben enthaltende immunogene zusammensetzungen.
AU569722B2 (en) * 1983-01-28 1988-02-18 Saramane Pty Ltd Expression of plasmodium falciparum polypeptides from cloned cdna
GB8404378D0 (en) * 1984-02-20 1984-03-28 Biogen Nv Dna sequence recombinant dna molecules
WO1985003724A1 (en) * 1984-02-21 1985-08-29 National Research Development Corporation Improvements in or relating to the production of malaria vaccines

Also Published As

Publication number Publication date
IT1180160B (it) 1987-09-23
GB2145092A (en) 1985-03-20
AU571202B2 (en) 1988-04-14
ZA84638B (en) 1984-09-26
IL70800A0 (en) 1984-04-30
GB2145092B (en) 1988-04-07
EP0134242A1 (de) 1985-03-20
DE3486159T2 (de) 1993-09-16
DE3486159D1 (de) 1993-07-15
AU2570984A (en) 1984-08-15
NZ230526A (en) 1990-10-26
IE840190L (en) 1984-07-28
JPS60500215A (ja) 1985-02-21
DK461884A (da) 1984-09-27
GB8402211D0 (en) 1984-02-29
GB2138426A (en) 1984-10-24
WO1984002922A1 (en) 1984-08-02
GB2138426B (en) 1988-04-07
GB8302349D0 (en) 1983-03-02
IT8419343A0 (it) 1984-01-27
EP0134242A4 (de) 1985-07-01
IL70800A (en) 1991-09-16
DK461884D0 (da) 1984-09-27
NZ206960A (en) 1990-06-26
EP0134242B1 (de) 1993-06-09
IE56627B1 (en) 1991-10-23

Similar Documents

Publication Publication Date Title
ATE90388T1 (de) Schuetzendes peptid-antigen.
PT584348E (pt) Vacina genetica para virus da imunodeficiencia
DE69127440D1 (de) Lebende vakzine
ATE496630T1 (de) Immunologische zusammensetzung und impfstoffe, die einen auf n-formyl-methionyl peptide bestehenden adjuvans enthalten
DE69831594D1 (de) Intakte oder zerstörte insektenzellen als antigenadjuvant
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
KR860004146A (ko) 경구용 백신의 제조방법
ATE72400T1 (de) Kreuzreaktive und schuetzende epitope von circumsporozoit-proteinen.
JPS6470498A (en) Synthetic peptide and antibody thereto
KR890003958A (ko) 단일클로온 항체들에 의해 확인되는 리스테리아속-특이 항원
DE68927350D1 (de) Gentechnologisch hergestellter coccidiose-impfstoff
EP0320866A3 (de) Schützendes immundominantes Epitop in der S1-Untereinheit von Pertussistoxin
PT84976A (pt) Method of producing feline leukemia virus antigens containing recombinant polypeptides
KR890008318A (ko) 플라스모듐 팔시파룸의 재조합 히스티딘-고함유 단백질, 이의 제조방법 및 용도
KR920012116A (ko) 말라리아 항원 hrpii 및 serp의 부분-서열들을 함유하는 보호적 플라스모듐 팔시파룸 하이브리드 단백질, 이의 제조방법 및 이의 용도
ZA896942B (en) Allelic variants of plasmodium falciparum merozoite surface antigen
MY106940A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.
GB2244273A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.